RECORDATI |
Market Closed -
Other stock markets
|
After market 03:59:59 pm | |||
| 48.52 EUR | -1.30% |
|
48.73 | +0.43% |
| May. 21 | Global markets live: Microsoft, Roche, BMW, Nintendo, Nordson... |  |
| May. 20 | Recordati purchased treasury shares for EUR3.8 million | AN |
| Sales 2024 * | 2.3B 2.49B | Sales 2025 * | 2.44B 2.64B | Capitalization | 10.11B 10.95B |
|---|---|---|---|---|---|
| Net income 2024 * | 478M 517M | Net income 2025 * | 524M 567M | EV / Sales 2024 * | 4.96 x |
| Net Debt 2024 * | 1.3B 1.41B | Net Debt 2025 * | 1.08B 1.17B | EV / Sales 2025 * | 4.59 x |
| P/E ratio 2024 * |
21.9
x | P/E ratio 2025 * |
19.7
x | Employees | 4,455 |
| Yield 2024 * |
2.86% | Yield 2025 * |
3.15% | Free-Float | 46.44% |
More Fundamentals
* Assessed data
More news
Latest transcript on Recordati
More press releases
| 1 day | -1.02% | ||
| 1 week | -4.21% | ||
| Current month | -2.78% | ||
| 1 month | -7.49% | ||
| 3 months | -7.98% | ||
| 6 months | +9.23% | ||
| Current year | -0.35% |
1 week
48.50
51.50
1 month
48.3853.40
Current year
47.2953.40
1 year
40.6253.40
3 years
34.5257.90
5 years
28.2657.90
10 years
11.3057.90
| Managers | Title | Age | Since |
|---|---|---|---|
Robert Koremans
CEO | Chief Executive Officer | 61 | 21-11-30 |
Luigi la Corte
DFI | Director of Finance/CFO | 54 | 19-10-31 |
Andrea Recordati
CHM | Chairman | 52 | 98-04-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Cathrin Petty
BRD | Director/Board Member | 51 | 18-06-11 |
Giampiero Mazza
BRD | Director/Board Member | 55 | 18-06-11 |
Robert Koremans
CEO | Chief Executive Officer | 61 | 21-11-30 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.52% | 5 M€ | +12.55% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-23 | 48.52 | -1.30% | 220 363 |
| 24-05-22 | 49.16 | +0.70% | 321,313 |
| 24-05-21 | 48.82 | -3.04% | 397,248 |
| 24-05-20 | 50.35 | -1.66% | 120,152 |
| 24-05-17 | 51.2 | +0.79% | 247,656 |
Real-time Borsa Italiana, May 23, 2024 at 11:15 am EDT
More quotes
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
49.16
EUR
Average target price
52.24
EUR
Spread / Average Target
+6.27%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -0.35% | 10.96B | |
| +38.65% | 723B | |
| +34.28% | 595B | |
| -3.16% | 369B | |
| +20.77% | 332B | |
| +2.92% | 282B | |
| +17.23% | 244B | |
| +9.20% | 208B | |
| -4.87% | 205B | |
| +0.12% | 168B |
- Stock Market
- Equities
- REC Stock
